Status:

COMPLETED

A Study for the Assessment of the Words Used by Patients and Physicians to Express Asthma Symptoms

Lead Sponsor:

AstraZeneca

Conditions:

Asthma

Eligibility:

All Genders

18+ years

Brief Summary

The purpose of the study is to evaluate the concordance of the most frequently used words by the patients and the physicians to express asthma symptoms and the limitations of daily activities caused b...

Eligibility Criteria

Inclusion

  • Diagnosis of persistent asthma treated with inhaled corticosteroid-based maintenance treatment for at least 6 months and followed up by the investigator for at least the same period of time

Exclusion

  • Patient with a cardiac disease (congestive heart failure, coronary heart disease)
  • Patient with a respiratory disease other than asthma (COPD, sleep apnoea syndrome)

Key Trial Info

Start Date :

September 1 2009

Trial Type :

OBSERVATIONAL

Allocation :

ACTUAL

End Date :

December 1 2009

Estimated Enrollment :

696 Patients enrolled

Trial Details

Trial ID

NCT00986219

Start Date

September 1 2009

End Date

December 1 2009

Last Update

December 17 2009

Active Locations (40)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 10 (40 locations)

1

Research Site

Pátrai, Achaia, Greece

2

Research Site

Agrinio, Aitoloakarnanias, Greece

3

Research Site

Thérmo, Aitoloakarnanias, Greece

4

Research Site

Naupaktos, Aitoloakarnania, Greece

A Study for the Assessment of the Words Used by Patients and Physicians to Express Asthma Symptoms | DecenTrialz